Mohammad Yasin Zamanian
- Soʻnggi maʼlum muassasa:
- Hamedan University of Medical Sciences
- ORCID:
- 0000-0003-0944-0320
2
h-indeks
0
i10-indeksi
10
Iqtiboslar
12
Asarlar
Vaqt boʻyicha
Vaqt boʻyicha tahlil
Iqtibos sharhi
Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)
- Nashrlar
- Iqtiboslar
Iqtibos tarixi
Nashr tarixi
h-indeks evolyutsiyasi
Yillar boʻyicha jamlangan h-indeks
Eng koʻp iqtibos qilingan asarlar
- Effects of Resveratrol on Nonmelanoma Skin Cancer ( <scp>NMSC</scp> ): A Comprehensive Review20241 iqtibos
- A comprehensive view on the quercetin impact on bladder cancer: Focusing on oxidative stress, cellular, and molecular mechanisms20230 iqtibos
- Neuroprotective effects of resveratrol on retinal ganglion cells in glaucoma: Focusing on oxidative stress, cellular, and molecular mechanisms20240 iqtibos
- Chemopreventive and Anticancer Role of Resveratrol20240 iqtibos
- A narrative review on therapeutic potential of naringenin in colorectal cancer: Focusing on molecular and biochemical processes20240 iqtibos
- Neuroprotective effects of resveratrol on retinal ganglion cells in glaucoma in rodents: A narrative review20240 iqtibos
- A Narrative Review on Therapeutic Potential of Naringenin in Colorectal Cancer: Focusing on molecular and biochemical processes20240 iqtibos
- Omentin-1 as a promising biomarker and therapeutic target in hypertension and heart failure: a comprehensive review20250 iqtibos
- The Role of ΔFosB in the Pathogenesis of Levodopa-Induced Dyskinesia: Mechanisms and Therapeutic Strategies20250 iqtibos
Hammualliflar
- Maryam Golmohammadi7 ta umumiy asarSkelet yozuvlar: 12023–2024
- Beneen M. Hussien4 ta umumiy asar2024
- Niloofar Taheri3 ta umumiy asarSkelet yozuvlar: 12023–2024
- Niyousha Shirsalimi3 ta umumiy asar2024–2025
- Ibrohim B. Sapaev3 ta umumiy asar2024
- Gervason Moriasi3 ta umumiy asar2024
- Mohammad Reza Rahmani2 ta umumiy asarSkelet yozuvlar: 12017–2024
- Enwa Felix Oghenemaro2 ta umumiy asar2025
- Parjinder Kaur2 ta umumiy asar2025
- I.B. Sapaev2 ta umumiy asar2024–2025